#RareDisease research takes time, but the results can be life changing. Experts from @NIDCR and @NIDDKgov who study FD/MAS know this well. Read about their years-long journey to answers in NIH @MedlinePlus Magazine! https://t.co/yrQQOZL4w4
My first large grant focused on advancing functional lung imaging with V/Q PET/CT
Co-lead with @_ShankarSiva
A huge body of work has ensued with nuclear medicine, radiation oncology, medical physics, respiratory medicine, cardiothoracic surgery and haematology!
Just out is @NickWBucknell latest research of functional lung avoidance using PET V/Q
https://t.co/0d1hkNx0SM
Very excited to join the @mghradchiefs!couldn’t have done it without the unwavering support of @MoozhanNikpanah, my family, and friends. Many thanks to all my mentors for their guidance along the way!
Boost your #FHIR skills with #SIIMTraining Core Essentials Live: HL7® FHIR®! Join @mohannadhussain & explore the paradigms including messaging, documents, REST protocol, services & conformance.
Multiple date options: May 2 / Aug 15 / Oct 31
Virtual-Live | https://t.co/ofMHUVghEW
ASTRO now supports no mandated physical presence of the rad onc MD in the clinic
I think I'm not telling tales out of school to say @ASTRO_org has rather vehemently opposed this in the past for #radonc
Letter to CMS today:
#wmic2023. Had the honor of meeting with many past, present and future presidents shown at @WMISWMIC Prague. Looking forward to future @SNM_MI @WMISWMIC Collaborations
Looking forward to the 2023 annual @EANM_NucMed meeting in Vienna. Our #Qurit team & collaborators will be presenting 14 works on digital twins, theranostics, dosimetry, AI & radiomics, image recon, standardization and beyond:
https://t.co/pnFz2U7K0Q
#EANM23
In cancer research, lessons learnt from other diseases are proving invaluable. Here we delve into some of the most promising new techniques in the fight against cancer. https://t.co/VswjtgYEjW
For 25 years, #NIDCR scientists have been looking for better ways to treat #FDMAS, a rare disorder of the bones, skin, & endocrine system. From basic research to clinical trials, researchers are delivering hope, answers, & potential therapies. https://t.co/wNbg8vek6e #NIDCR75
It’s the time for change: Johannes Czernin Discusses the Future of #Theranostics with Ebrahim Delpassand, Eric Rohren, and Wolfgang Weber. https://t.co/UwNGMPCfKG
#NuclearMedicine@DrEMRohren @CzerninJohannes
Our perspective paper in @ElsevierConnect Science Bulletin:
"Radiopharmaceutical therapy on-a-chip: a perspective on microfluidic-driven digital twins towards personalized cancer therapies"
https://t.co/ZgfmFOmXL9
Led by Hamid Abdollahi @nasehabad
@babaksaboury@CarlosUribeM